Trial site
Kadima Neuropsychiatry Institute
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Depression11 trials
- Phase
- Phase 37 trials
- Phase 24 trials
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Enrolling by invitation2 trials
- Recruiting2 trials
- Lead sponsor
- COMPASS Pathways3 trials
- Cybin IRL Limited2 trials
- Definium Therapeutics US, Inc.2 trials
- ACADIA Pharmaceuticals Inc.1 trial
- atai Therapeutics, Inc.1 trial
- and 4 more
Running trials
Recruiting
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Recruiting
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Enrolling by invitation
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Active, not recruiting
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)
Active, not recruiting
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Active, not recruiting
Enrolling by invitation
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
Active, not recruiting
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression3 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026